A PHASE II STUDY OF APATINIB PLUS TEMOZOLOMIDE IN ADULTS WITH REFRACTORY RECURRENT HIGH-GRADE GLIOMAS

被引：0
|
作者：
Zhang, Jun-ping [1 ]
Ge, Jing-jing [1 ]
Li, Cheng [1 ]
机构：
[1] Capital Med Univ, Sanbo Brain Hosp, Dept Neurooncol, Beijing, Peoples R China
来源：
NEURO-ONCOLOGY | 2018年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ACTR-08
引用
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [1] Clinical study of apatinib plus temozolomide for the treatment of recurrent high-grade gliomas
    Yao, Hui
    Liu, Jiangang
    Zhang, Chi
    Shao, Yunxiang
    Li, Xuetao
    Feng, Ming
    Wang, Ximing
    Gan, Wenjuan
    Zhou, Youxin
    Huang, Yulun
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2021, 90 : 82 - 88
  • [2] Phase I study of Gliadel™ wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas
    Gururangan, S
    Cokgor, I
    Rich, JN
    Edwards, S
    Affronti, ML
    Quinn, JA
    Herndon, JE
    Provenzale, JM
    McLendon, RE
    Tourt-Uhlig, S
    Sampson, JH
    Stafford-Fox, V
    Zaknoen, S
    Early, M
    Friedman, AH
    Friedman, HS
    [J]. NEURO-ONCOLOGY, 2001, 3 (04) : 246 - 250
  • [3] A phase I study of temozolomide and lapatinib combination in patients with recurrent high-grade gliomas
    Karavasilis, Vasilios
    Kotoula, Vassiliki
    Pentheroudakis, George
    Televantou, Despina
    Lambaki, Sofia
    Chrisafi, Sofia
    Bobos, Mattheos
    Fountzilas, George
    [J]. JOURNAL OF NEUROLOGY, 2013, 260 (06) : 1469 - 1480
  • [4] A phase I study of temozolomide and lapatinib combination in patients with recurrent high-grade gliomas
    Vasilios Karavasilis
    Vassiliki Kotoula
    George Pentheroudakis
    Despina Televantou
    Sofia Lambaki
    Sofia Chrisafi
    Mattheos Bobos
    George Fountzilas
    [J]. Journal of Neurology, 2013, 260 : 1469 - 1480
  • [5] NEOADJUVANT CAMRELIZUMAB AND APATINIB IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMAS:PRIMARY REPORT OF AN OPEN LABEL PHASE II STUDY
    Chen, Z.
    Guo, C.
    Yang, Q.
    Hu, W.
    Cao, X.
    Liao, Y.
    Zhang, J.
    Jiang, X.
    Li, D.
    Chen, Y.
    [J]. NEURO-ONCOLOGY, 2023, 25
  • [6] A PHASE II STUDY OF THE EFFICACY OF HYPOFRACTIONATED RADIATION THERAPY WITH BEVACIZUMAB AND TEMOZOLOMIDE FOLLOWED BY MAINTENANCE TEMOZOLOMIDE AND BEVACIZUMAB FOR RECURRENT HIGH-GRADE GLIOMAS
    Dixit, Karan
    Kumthekar, Priya
    Kruser, Timothy
    Sachdev, Sean
    Kalapurakal, John A.
    Gondi, Vinai
    Grimm, Sean
    Nicholas, Martin
    Lukas, Rimas V.
    Chmura, Steven J.
    Mehta, Minesh P.
    Raizer, Jeffrey
    [J]. NEURO-ONCOLOGY, 2017, 19 : 19 - 20
  • [7] Phase II study of two-weekly temozolomide in patients with high-grade gliomas
    Wong, S
    Rosenthal, MA
    Dowling, A
    Jennens, R
    Woods, AM
    Ashley, D
    Cher, L
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2006, 13 (01) : 18 - 22
  • [8] Phase II trial of sunitinib malate in patients with temozolomide refractory recurrent high-grade glioma
    Neyns, B.
    Chaskis, C.
    Dujardin, M.
    Everaert, H.
    Sadones, J.
    Nupponen, N. N.
    Michotte, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [9] Multi-institutional phase II study of temozolomide administered twice daily in the treatment of recurrent high-grade gliomas
    Balmaceda, Casilda
    Peereboom, David
    Pannullo, Susan
    Cheung, Ying Kuen K.
    Fisher, Paul G.
    Alavi, Jane
    Sisti, Michael
    Chen, Johnson
    Fine, Robert L.
    [J]. CANCER, 2008, 112 (05) : 1139 - 1146
  • [10] Multicenter phase and II trials in adults with high-grade gliomas
    不详
    [J]. ONCOLOGY-NEW YORK, 1999, 13 (04): : 532 - +
12345